From: Rho GTPases as therapeutic targets in Alzheimer’s disease
Model | Rho GTPase alterations | Reference |
---|---|---|
Tg2576 hAPP Swedish (KM670/671NL) | • 12- to 18-month-old, overall ↑ RhoA and ↓ Rac1 in brain • 18-month-old, RhoA ↓ synapse and ↑ distrophic neurites • 18-month-old, ↑ Rac1 in cortex | |
hAPP J20 hAPP Swedish, Indiana (V717F) | • 14-month-old, ↑ RhoA hippocampus | [38] |
5 × FAD/Tg6799 hAPP Swedish, Florida (I716V), London (V717I); PSEN1 (M146L/L286V) | • 9- to 10-month-old, ↑ RhoA brain capillaries | [39] |
AD patients | • ↓ Rac1 early stage AD • ↑ Cdc42 and Rac1 in select neuronal populations • ↓ Rac1 and PAK1 in frontal and occipital lobes • RhoA ↓ in neuropils, ↑ neurons, and colocalized with hyperphosphorylated tau leading to ↓ RhoA activity |